Skip to Content
Merck
  • Amazon rainforest rodents (Proechimys) are resistant to post-stroke epilepsy.

Amazon rainforest rodents (Proechimys) are resistant to post-stroke epilepsy.

Scientific reports (2021-08-20)
Nancy N Ortiz-Villatoro, Selvin Z Reyes-Garcia, Leandro Freitas, Laís D Rodrigues, Luiz E C Santos, Jean Faber, Esper A Cavalheiro, Josef Finsterer, Fulvio A Scorza, Antônio C G de Almeida, Carla A Scorza
ABSTRACT

There are no clinical interventions to prevent post-injury epilepsy, a common and devastating outcome after brain insults. Epileptogenic events that run from brain injury to epilepsy are poorly understood. Previous studies in our laboratory suggested Proechimys, an exotic Amazonian rodent, as resistant to acquired epilepsy development in post-status epilepticus models. The present comparative study was conducted to assess (1) stroke-related brain responses 24-h and 30 days after cortical photothrombosis and (2) post-stroke epilepsy between Proechimys rodents and Wistar rats, a traditional animal used for laboratory research. Proechimys group showed smaller volume of ischemic infarction and lesser glial activation than Wistar group. In contrast to Wistar rats, post-stroke decreased levels of pro-inflammatory cytokines and increased levels of anti-inflammatory mediators and growth factors were found in Proechimys. Electrophysiological signaling changes assessed by cortical spreading depression, in vitro and in vivo, showed that Wistar's brain is most severely affected by stroke. Chronic electrocorticographic recordings showed that injury did not lead to epilepsy in Proechimys whereas 88% of the Wistar rats developed post-stroke epilepsy. Science gains insights from comparative studies on diverse species. Proechimys rodents proved to be a useful animal model to study antiepileptogenic mechanisms after brain insults and complement conventional animal models.

MATERIALS
Product Number
Brand
Product Description

Millipore
MILLIPLEX® TGFß1 Magnetic Bead Single Plex Kit - Immunology Multiplex Assay, This Immunology Multiplex Assay is used for the simultaneous quantification of the TGF-β1 biomarker in the following species: Mouse/Human/Rat/Pig/Horse/Rabbit/Guinea Pig/Hamster.